| Kristen Taylor Bracy, MD | |
|
9500 Baptist Health Dr Ste 100, Little Rock, AR 72205-6340 | |
| (501) 224-5500 | |
| (501) 224-1166 |
| Full Name | Kristen Taylor Bracy |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 14 Years |
| Location | 9500 Baptist Health Dr Ste 100, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033434527 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 132951 (California) | Secondary |
| 207V00000X | Obstetrics & Gynecology | E-10127 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Medical Center-little Rock | Little rock, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cornerstone Clinic For Women | 5092629352 | 17 |
News Archive
Blood pressure control of people 80 years and older, especially women, must be made a national priority, urged a Northwestern University researcher at the American Society of Hypertension's Nineteenth Annual Scientific Meeting.
Retinoic acid (RA), a natural derivative of vitamin A, is the basis of a number of treatments against cancer. Nevertheless, it has certain disadvantages, such as the possibility of the appearance of retinoic acid syndrome, present in 25 % of cases and which can lead to death. The development of 4-HPR, a synthetic derivative of RA, has meant a considerable advance due to its greater efficacy compared to its predecessor.
Sealand Natural Resources Inc., a new product development company which manufactures, markets and sells functional beverages (Sealand BIRK), today announced an exclusive distribution agreement in Sweden with the V-SELL Group.
S*BIO Pte Ltd today announced that the European Commission (EC) has granted orphan drug designation to SB1518, its potent and orally active JAK2 inhibitor for the treatment of primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) and post-essential thrombocythemia myelofibrosis (PET-MF). SB1518 has also received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of the same disorder.
› Verified 7 days ago
| Entity Name | Cornerstone Clinic For Women |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700853553 PECOS PAC ID: 5092629352 Enrollment ID: O20031119000560 |
News Archive
Blood pressure control of people 80 years and older, especially women, must be made a national priority, urged a Northwestern University researcher at the American Society of Hypertension's Nineteenth Annual Scientific Meeting.
Retinoic acid (RA), a natural derivative of vitamin A, is the basis of a number of treatments against cancer. Nevertheless, it has certain disadvantages, such as the possibility of the appearance of retinoic acid syndrome, present in 25 % of cases and which can lead to death. The development of 4-HPR, a synthetic derivative of RA, has meant a considerable advance due to its greater efficacy compared to its predecessor.
Sealand Natural Resources Inc., a new product development company which manufactures, markets and sells functional beverages (Sealand BIRK), today announced an exclusive distribution agreement in Sweden with the V-SELL Group.
S*BIO Pte Ltd today announced that the European Commission (EC) has granted orphan drug designation to SB1518, its potent and orally active JAK2 inhibitor for the treatment of primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) and post-essential thrombocythemia myelofibrosis (PET-MF). SB1518 has also received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of the same disorder.
› Verified 7 days ago
| Entity Name | Baptist Medcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699868323 PECOS PAC ID: 5698667624 Enrollment ID: O20040325001348 |
News Archive
Blood pressure control of people 80 years and older, especially women, must be made a national priority, urged a Northwestern University researcher at the American Society of Hypertension's Nineteenth Annual Scientific Meeting.
Retinoic acid (RA), a natural derivative of vitamin A, is the basis of a number of treatments against cancer. Nevertheless, it has certain disadvantages, such as the possibility of the appearance of retinoic acid syndrome, present in 25 % of cases and which can lead to death. The development of 4-HPR, a synthetic derivative of RA, has meant a considerable advance due to its greater efficacy compared to its predecessor.
Sealand Natural Resources Inc., a new product development company which manufactures, markets and sells functional beverages (Sealand BIRK), today announced an exclusive distribution agreement in Sweden with the V-SELL Group.
S*BIO Pte Ltd today announced that the European Commission (EC) has granted orphan drug designation to SB1518, its potent and orally active JAK2 inhibitor for the treatment of primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) and post-essential thrombocythemia myelofibrosis (PET-MF). SB1518 has also received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of the same disorder.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristen Taylor Bracy, MD 2930 Metamora Rd, Metamora, MI 48455-9275 Ph: (858) 414-2071 | Kristen Taylor Bracy, MD 9500 Baptist Health Dr Ste 100, Little Rock, AR 72205-6340 Ph: (501) 224-5500 |
News Archive
Blood pressure control of people 80 years and older, especially women, must be made a national priority, urged a Northwestern University researcher at the American Society of Hypertension's Nineteenth Annual Scientific Meeting.
Retinoic acid (RA), a natural derivative of vitamin A, is the basis of a number of treatments against cancer. Nevertheless, it has certain disadvantages, such as the possibility of the appearance of retinoic acid syndrome, present in 25 % of cases and which can lead to death. The development of 4-HPR, a synthetic derivative of RA, has meant a considerable advance due to its greater efficacy compared to its predecessor.
Sealand Natural Resources Inc., a new product development company which manufactures, markets and sells functional beverages (Sealand BIRK), today announced an exclusive distribution agreement in Sweden with the V-SELL Group.
S*BIO Pte Ltd today announced that the European Commission (EC) has granted orphan drug designation to SB1518, its potent and orally active JAK2 inhibitor for the treatment of primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) and post-essential thrombocythemia myelofibrosis (PET-MF). SB1518 has also received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of the same disorder.
› Verified 7 days ago
Dr. Francisco Batres, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 9101 Kanis Rd, Suite 300, Little Rock, AR 72205 Phone: 501-801-1200 Fax: 501-801-1207 | |
Dr. Kristin K Zorn, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
David Hutchins, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
Dayna D Whitcombe, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6119 Midtown Ave, Little Rock, AR 72205 Phone: 501-296-1800 Fax: 501-296-1711 | |
Nafisa Dajani, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
Jennifer Afton Cooper, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5 Saint Vincent Cir Ste 300, Little Rock, AR 72205 Phone: 501-552-8800 Fax: 501-552-5343 |